PKC θ Pseudo-substrate inhibitor MF: C91H157N35O21S
MW: 2109.5
Inhibitor for in vitro PKCθ kinase assays.

PKC θ Pseudo-substrate inhibitor

PKC θ Pseudo-substrate Inhibitor is rated 5.0 out of 5 by 1.
  • y_2021, m_9, d_19, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_3097, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 132ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Alternate Names: Protein Kinase Cθ Pseudosubstrate Inhibitor; LHQRRGAIKQAKVHHVKC
Application: PKC θ Pseudo- substrate Inhibitor is inhibitor for in vitro PKCθ kinase assays
Purity: ≥97% by HPLC
Molecular Weight: 2109.5
Molecular Formula: C91H157N35O21S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

PKC θ Pseudo-substrate inhibitor is a protein kinase Cθ pseudosubstrate peptide that can be used as a competitive inhibitor for in vitro PKC θ kinase assays.


References

1. Osada, S., Mizuno, K., Saido, T.C., Suzuki, K., Kuroki, T. and Ohno, S. 1992. A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol. Cell. Biol. 12(9): 3930-3938. PMID: 1508194

Usage :
Recommended reaction conditions: PKCθ-containing sample is incubated at 30 - 37°C, with or without 400 μM PKC θ Pseudo-substrate inhibitor, in 50 mM Tris buffer (pH 7.5) containing 5 mM MgCl2, 0.1 mM Na3VO4, 0.1 mM Na4P2O7, 1 mM NaF, 0.1 mM PMSF, 50 μM ATP, 5 μCi [γ-32P]ATP, 4 μg phosphatidylserine, and 40 μM PKCθ substrate (sc-3107).

Storage:Protect from moisture. After reconstitution, aliquot and freeze (-20°C). This product is stable for 2 years as supplied. Stock solutions are stable for 6 months -20°C.
Appearance :
Lyophilized
Physical State :
Solid
Sequence :
Leu-His-Gln-Arg-Arg-Gly-Ala-Ile-Lys-Gln-Ala-Lys-Val-His-His-Val-Lys-Cys-OH
Solubility :
Soluble in water.
Storage :
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

PKC θ Pseudo-substrate inhibitor  Product Citations

See how others have used PKC θ Pseudo-substrate inhibitor. Click on the entry to view the PubMed entry .

Citations 1 to 3 of 3 total

PMID: # 28369981  Wang, Y.|Zhou, Q.|Wu, B.|Zhou, H.|Zhang, X.|Jiang, W.|Wang, L.|Wang, A.| et al. 2017. Br J Pharmacol. 174: 1984-2000.

PMID: # 25277212  Leung, CS. et al. 2014. Nature communications. 5: 5092.

PMID: # 19706599  Gayen, JR. et al. 2009. The Journal of biological chemistry. 284: 28498-509.

Citations 1 to 3 of 3 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 92ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Various publications cite the use of PKC Pseudo Various publications cite the use of PKC Pseudo-substrate inhibitor, a protein kinase C pseudosubstrate peptide, as a competitive inhibitor for in vitro PKC kinase assays. -SCBT Publication Review
Date published: 2015-01-25
  • y_2021, m_9, d_19, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_3097, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT